1 Ocak 2012 Dergi makalesi Açık Erişim

Kabasakal, Levent; Demirci, Emre; Ocak, Meltem; Decristoforo, Clemens; Araman, Ahmet; Ozsoy, Yildiz; Uslu, Ilhami; Kanmaz, Bedii

DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/84321</identifier>
  <creators>
    <creator>
      <creatorName>Kabasakal, Levent</creatorName>
      <givenName>Levent</givenName>
      <familyName>Kabasakal</familyName>
    </creator>
    <creator>
      <creatorName>Demirci, Emre</creatorName>
      <givenName>Emre</givenName>
      <familyName>Demirci</familyName>
      <affiliation>Istanbul Univ, Dept Nucl Med, Cerrahpasa Med Fac, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ocak, Meltem</creatorName>
      <givenName>Meltem</givenName>
      <familyName>Ocak</familyName>
      <affiliation>Istanbul Univ, Dept Pharmaceut Technol, Fac Pharm, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Decristoforo, Clemens</creatorName>
      <givenName>Clemens</givenName>
      <familyName>Decristoforo</familyName>
      <affiliation>Med Univ Innsbruck, Clin Dept Nucl Med, Innsbruck, Austria</affiliation>
    </creator>
    <creator>
      <creatorName>Araman, Ahmet</creatorName>
      <givenName>Ahmet</givenName>
      <familyName>Araman</familyName>
      <affiliation>Istanbul Univ, Dept Pharmaceut Technol, Fac Pharm, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Ozsoy, Yildiz</creatorName>
      <givenName>Yildiz</givenName>
      <familyName>Ozsoy</familyName>
      <affiliation>Istanbul Univ, Dept Pharmaceut Technol, Fac Pharm, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Uslu, Ilhami</creatorName>
      <givenName>Ilhami</givenName>
      <familyName>Uslu</familyName>
      <affiliation>Istanbul Univ, Dept Nucl Med, Cerrahpasa Med Fac, Istanbul, Turkey</affiliation>
    </creator>
    <creator>
      <creatorName>Kanmaz, Bedii</creatorName>
      <givenName>Bedii</givenName>
      <familyName>Kanmaz</familyName>
      <affiliation>Istanbul Univ, Dept Nucl Med, Cerrahpasa Med Fac, Istanbul, Turkey</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Comparison Of Ga-68-Dotatate And Ga-68-Dotanoc Pet/Ct Imaging In The Same Patient Group With Neuroendocrine Tumours</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2012</publicationYear>
  <dates>
    <date dateType="Issued">2012-01-01</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/84321</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1007/s00259-012-2123-y</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">Recent studies have suggested that positron emission tomography (PET) imaging with Ga-68-labelled DOTA-somatostatin analogues (SST) like octreotide and octreotate is useful in diagnosing neuroendocrine tumours (NETs) and has superior value over both CT and planar and single photon emission computed tomography (SPECT) somatostatin receptor scintigraphy (SRS). The aim of the present study was to evaluate the role of Ga-68-DOTA-1-NaI3-octreotide (Ga-68-DOTANOC) in patients with SST receptor-expressing tumours and to compare the results of Ga-68-DOTA-D-Phe(1)-Tyr(3)-octreotate (Ga-68-DOTATATE) in the same patient population.</description>
  </descriptions>
</resource>